Surgical removal of part of an occluder to treat iatrogenic coarctation of the aorta: a case report

Sun, Zhongwei; Li, Dongxu; Wang, Yabo; An, Qi

doi:10.1186/s12893-020-0682-6

Cited by 4 publications

(2 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This was essentially a reflection of the severity of the injury and the severity of the inflammatory response, which just proved that the pseudoperimembranous aneurysm was an active tissue that can proliferate continuously. The aneurysmal perimembranous tissue was continuously damaged by the impact of blood flow, and the continuous inflammatory response made the aneurysmal perimembranous tissue continue to proliferate [ 22 ]. This ability to proliferate allowed the larger defects of the VSD to shrink or even close.…”

Section: Discussionmentioning

confidence: 99%

[Retracted] Study on Inflammatory Factors in Aneurysmal Perimembranous Ventricular Septal Defect in Congenital Heart Disease

Zhou

Liu

Wang

et al. 2022

BioMed Research International

View full text Add to dashboard Cite

To detect the expression of inflammatory factors such as interleukin-1β (IL-1β), interleukin-6 (IL-6), transforming growth factor (TGF-β), and tumor necrosis factor (TNF-α) in the tumor tissue of ventricular septal defect (VSD) in congenital heart disease and to explore the role of inflammatory response in the formation of aneurysmal perimembranous VSD(APVSD). Children with APVSD of congenital heart disease treated by surgery were selected and divided into true aneurysmal perimembranous group (TAP group) and pseudoaneurysmal perimembranous group (PAP group) according to echocardiography and surgical findings. There were 15 children in the TAP group and 31 in the PAP group. The aneurysmal perimembranous tissue of the two groups of children was collected during the operation. IL-1β, IL-6, TGF-β, and TNF-α were positively expressed in the aneurysmal perimembranous tissue of the two groups, and the expression levels of all inflammatory factors in the PAP group were higher than those in the TAP group, and the difference was statistically significant ( P < 0.05 ). The expression levels of IL-1β, IL-6, TGF-β, and TNF-α in the aneurysmal perimembranous tissue of the two groups were negatively correlated with the width of the APVSD breach. IL-1β, IL-6, TGF-β, and TNF-α may be involved in the occurrence and development of APVSD through inflammatory mechanism.

show abstract

Section: Discussionmentioning

confidence: 99%

[Retracted] Study on Inflammatory Factors in Aneurysmal Perimembranous Ventricular Septal Defect in Congenital Heart Disease

Zhou

Liu

Wang

et al. 2022

BioMed Research International

View full text Add to dashboard Cite

show abstract

“…For the percutaneous transcatheter closure of the symptomatic PDA, Amplatzer duct occluders (ADOs) are commonly used (2). In neonates or patients with specific PDA morphology, PDA device closure has been difficult due to the device protrusion into the thoracic aorta (3)(4)(5)(6)(7)(8). The right angle between the plug and disc causes the protrusion of the disc into the thoracic aorta because most PDA cases have an acute angle with the thoracic aorta.…”

Section: Introductionmentioning

confidence: 99%

Angle Formed Between Patent Ductus Arteriosus and Descending Thoracic Aorta in a Beating Heart: A Helpful Study to Design a Better Device for Occluding Patent Ductus Arteriosus

Lee

Ban

et al. 2021

Iran J Pediatr

View full text Add to dashboard Cite

Background: The percutaneous transcatheter closure of patent ductus arteriosus (PDA) has been a widely used treatment method. However, PDA device closure in neonates or patients with specific PDA morphology has been difficult due to the protrusion of the device into the descending aorta. The right angle between the disc and plug causes some degree of protrusion of the disc into the descending aorta because normal PDA forms an acute angle with the descending aorta. Objectives: There have been limited data about the angles of PDA since Mancini’s study in 1951, and new studies are required in this regard. This study measured the angles between PDA and descending aorta through angiography in a beating heart. Methods: Within December 2008 to November 2016, 190 patients undergoing percutaneous PDA occlusion were included in this study. Retrospectively, the mean angle of PDA was measured by three cardiologists between the longitudinal axis of the descending aorta and the longitudinal axis of the PDA through an aortogram. The patients were divided into three groups according to age (group A: under 1, group B: 1-6, and group C: over 6 years of age) and PDA morphology based on Krichenko’s classification (type A: conical PDA, type B: window PDA, type C: tubular PDA, type D: complex PDA, and type E: elongated PDA). Results: Of 190 study patients, 135 patients were female, and the median age of the patients was 7 years (range: 75 days to 60 years). The mean angle of PDA was 48.2 ± 12.0°. There were no statistical differences regarding PDA angle among the groups classified by age and PDA morphology. Conclusions: The authors are hopeful that the obtained data will help develop a better device for the percutaneous transcatheter closure of PDA.

show abstract

Transcatheter closure of tubular patent ductus arteriosus using muscular ventricular septal defect devices in infants and small children with congestive heart failure

Salam

Bautista‐Rodriguez

Karsenty

et al. 2022

Archives of Cardiovascular Diseases

View full text Add to dashboard Cite

Surgical removal of part of an occluder to treat iatrogenic coarctation of the aorta: a case report

Cited by 4 publications

References 21 publications

[Retracted] Study on Inflammatory Factors in Aneurysmal Perimembranous Ventricular Septal Defect in Congenital Heart Disease

[Retracted] Study on Inflammatory Factors in Aneurysmal Perimembranous Ventricular Septal Defect in Congenital Heart Disease

Angle Formed Between Patent Ductus Arteriosus and Descending Thoracic Aorta in a Beating Heart: A Helpful Study to Design a Better Device for Occluding Patent Ductus Arteriosus

Transcatheter closure of tubular patent ductus arteriosus using muscular ventricular septal defect devices in infants and small children with congestive heart failure

Contact Info

Product

Resources

About